Across industries, a quiet revolution in leadership is underway. Boards and executive teams are rethinking how they access capability –

As we close out a period of sustained uncertainty, many leaders across pharma, medtech, and diagnostics are asking the same

In an industry where innovation accelerates faster than most leaders can keep up with, time can feel like a constant

Imposter syndrome is becoming increasingly common in healthcare and life sciences, affecting leaders at every level. Understanding how it shows

McKinsey’s latest outlook on the US healthcare market is more than a financial projection – it is a guide to

As we wrap up this year, I’ve been reflecting on just how significant – and unusual – it has been

As the sector compresses, strong leaders step forward Healthcare and life sciences are in a cycle of compression and pivot.

In a world where everyone has something to say, standing out isn’t about what you promise. It’s about what you’ve